Nidogen-2: A new biomarker in colon cancer patients
dc.authorid | Kemik, Ozgur/0000-0002-4612-1428 | |
dc.contributor.author | Kiziltan, Remzi | |
dc.contributor.author | Cikman, Oztekin | |
dc.contributor.author | Algul, Sermin | |
dc.contributor.author | Aydin, Mehmet Akif | |
dc.contributor.author | Kemik, Ozgur | |
dc.date.accessioned | 2025-02-06T17:58:26Z | |
dc.date.available | 2025-02-06T17:58:26Z | |
dc.date.issued | 2022 | |
dc.department | Altınbaş Üniversitesi | en_US |
dc.description.abstract | AIM: In the present study, we followed Nidogen-2 levels and clinicopathological parameters of patients with colon cancer. MATERIAL AND METHODS: Eighty-eight patients (F/M, 43/45; Mean age +/- SD, 57.86 +/- 1.78 years) were included. The results of serum Nidogen-2 levels were shown with respect to stage, gender, age, and metastasis. Nidogen-2 levels in the sera of colon cancer patients and healthy donors were analyzed with ELISA. RESULTS: The expression levels were significantly higher in patients (1010.8 +/- 184.36 pg/mL) than in healthy subjects (51.85 +/- 1.44 pg/mL; p<0.001). Moreover, the Nidogen-2 expression significantly increased in the clinical stages of colon cancer (p<0.01). The Nidogen-2 levels did not vary by patient age or gender. DISCUSSION: Under normal conditions, Nidogen-2 is a basal membrane protein. Nidogen-2 is primarily expressed in the extracellular matrix. Nidogen-2 has been defined as a major means to analyze the molecular pathways involved in cancer development and progression. Besides its important functions, it has been hypothesized that secreted Nidogen-2 may be a diagnostic biomarker for cancer detection. CONLUSION: These findings suggest that increased expression of Nidogen-2 may have great pathological importance in the development of colon cancer and may also show a diagnostic value for colon cancer. | en_US |
dc.identifier.endpage | 92 | en_US |
dc.identifier.issn | 0003-469X | |
dc.identifier.issn | 2239-253X | |
dc.identifier.issue | 1 | en_US |
dc.identifier.pmid | 34593672 | |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 88 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12939/5257 | |
dc.identifier.volume | 93 | en_US |
dc.identifier.wos | WOS:000886951900012 | |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.publisher | Edizioni Luigi Pozzi | en_US |
dc.relation.ispartof | Annali Italiani Di Chirurgia | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.snmz | KA_WOS_20250206 | |
dc.subject | Angiogenesis | en_US |
dc.subject | Metastasis | en_US |
dc.subject | Nidogen-2 | en_US |
dc.title | Nidogen-2: A new biomarker in colon cancer patients | en_US |
dc.type | Article | en_US |